Altered 𝐩𝟏𝟔^{𝐈𝐍𝐊𝟒} and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer

Table 2

Correlation of CDKN2A copy number variances with the outcome and the tumor types¹.

CDKN2A CPN	Survival*		Histologic type**
	Alive	Dead	Adenocarcinoma	Nonadenocarcinoma
CNV	6 (18.8)*	17 (41.5)	14 (27.5)	9 (40.9)
Normal	26 (81.2)	24 (58.5)	37 (72.7)	13 (49.1)

¹The data presented in the table in format of “case number (% of the same column)”.
Fisher’s probability exact test (two tailed): *𝑃=0.0455 and **𝑃=0.282.